Ian A. Blair

Papers

Total Citations

H-Index

About

Ian A. Blair is a pioneering figure in analytical chemistry and cancer pharmacology, whose work has fundamentally advanced the understanding of drug metabolism and oxidative stress. His research centers on the application of mass spectrometry to elucidate the mechanisms of anticancer drug action and toxicity, with a particular focus on how drug metabolites contribute to both therapeutic efficacy and adverse effects. Blair’s major contributions include developing sophisticated analytical methods to identify and quantify reactive intermediates, such as lipid peroxidation products and protein adducts, which are critical in diseases like cancer and neurodegeneration. His landmark paper, "Analysis of Anticancer Drugs and their Metabolites by Mass Spectrometry," laid the groundwork for modern pharmacodynamic studies, emphasizing the role of metabolites in drug response—a concept now central to personalized medicine. With over 10,000 citations across his career, Blair’s impact is profound, and his work has been recognized with prestigious awards, including the American Society for Mass Spectrometry’s Distinguished Contribution Award. His research continues to shape how scientists investigate drug safety and disease mechanisms, making him a vital resource for students and researchers in mass spectrometry and cancer biology.